Cargando…

Clinical Features, Strain Distribution, Antifungal Resistance and Prognosis of Patients with Non-albicans Candidemia: A Retrospective Observational Study

PURPOSE: Candida albicans (C. albicans) candidemia has been well reported in previous studies, while research on non-albicans Candida (NAC) bloodstream infections remains poorly explored. Therefore, the present study aimed to investigate the clinical characteristics and outcomes of patients with NAC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Fengqi, Zhong, Li, Zhou, Feifei, Zheng, Cheng, Zhang, Kai, Cai, Jiachang, Zhou, Hongwei, Tang, Kankai, Dong, Zhaohui, Cui, Wei, Zhang, Gensheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8380288/ https://www.ncbi.nlm.nih.gov/pubmed/34429621 http://dx.doi.org/10.2147/IDR.S323583

Ejemplares similares

Clinical characteristics, risk factors and outcomes of mixed Candida albicans/bacterial bloodstream infections
por: Zhong, Li, et al.
Publicado: (2020)

Incidence, clinical characteristics, risk factors and outcomes of patients with mixed Candida/bacterial bloodstream infections: a retrospective study
por: Zhong, Li, et al.
Publicado: (2022)

Epidemiology and antifungal susceptibility of candidemia isolates of non-albicans Candida species from cancer patients
por: Wu, Ping-Feng, et al.
Publicado: (2017)

Clinical Features and Outcomes of Persistent Candidemia Caused by Candida albicans versus Non-albicans Candida Species: A Focus on Antifungal Resistance and Follow-Up Blood Cultures
por: Kitaya, Shiori, et al.
Publicado: (2023)

2447. Clinical Features and Outcome of Persistent Candidemia Caused by Candida albicans versus Non-albicans Candida Species: A Focus on Antifungal Resistance and Follow-up Blood Cultures
por: Kitaya, Shiori, et al.
Publicado: (2023)

Comparison of albicans vs. non-albicans candidemia in French intensive care units
por: Leroy, Olivier, et al.
Publicado: (2010)

Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial Klebsiella pneumoniae Bloodstream Infections
por: Song, Feizhen, et al.
Publicado: (2021)

Emergence of Non-Albicans Candida Species in Neonatal Candidemia
por: Juyal, Deepak, et al.
Publicado: (2013)

Risk factors for fatal candidemia caused by Candida albicans and non-albicans Candida species
por: Cheng, Ming-Fang, et al.
Publicado: (2005)

Surveillance of Antifungal Resistance in Candidemia Fails to Inform Antifungal Stewardship in European Countries
por: Galia, Liliana, et al.
Publicado: (2022)

1981. Implementation of an Antifungal Stewardship Bundle Focused on Candidemia in an Indian Hospital
por: Moni, Merlin, et al.
Publicado: (2019)

Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia
por: Lindberg, Erika, et al.
Publicado: (2019)

Epidemiology, species distribution, antifungal susceptibility, and outcome of candidemia in intensive care units in Isfahan, Iran
por: Haghighatfard, Azam, et al.
Publicado: (2022)

The Role of Antifungals against Candida Biofilm in Catheter-Related Candidemia
por: Bouza, Emilio, et al.
Publicado: (2014)

Impact of empirical treatment with antifungal agents on survival of patients with candidemia
por: Poves-Alvarez, Rodrigo, et al.
Publicado: (2019)

Epidemiology, Species Distribution, Antifungal Susceptibility and Outcome of Nosocomial Candidemia in a Tertiary Care Hospital in Italy
por: Bassetti, Matteo, et al.
Publicado: (2011)

Epidemiology, risk factors, species distribution, and antifungal susceptibility of candidemia among hospitalized patients with COVID-19
por: Kamali Sarvestani, Hasti, et al.
Publicado: (2021)

Top-down characterization data on the speciation of the Candida albicans immunome in candidemia
por: Pitarch, Aida, et al.
Publicado: (2015)

High Virulence and Antifungal Resistance in Clinical Strains of Candida albicans
por: Monroy-Pérez, Eric, et al.
Publicado: (2016)

Epidemiology of Candida albicans and non-C.albicans of neonatal candidemia at a tertiary care hospital in western China
por: Fu, Jinjian, et al.
Publicado: (2017)

Surveillance study of species distribution, antifungal susceptibility and mortality of nosocomial candidemia in a tertiary care hospital in China
por: Ma, Chun-fang, et al.
Publicado: (2013)

Clinical features of patients with candidemia in sepsis
por: Komori, Akira, et al.
Publicado: (2019)

Epidemiology and Prognostic Factors of Non-albicans Candida species Candidemia: A Multicenter Study
por: Lee, Yu-Lin, et al.
Publicado: (2017)

Candida parapsilosis Candidemia Resistance Patterns and Treatment Outcomes: An Opportunity for Antifungal Stewardship
por: Fong, Gary, et al.
Publicado: (2017)

Species Distribution, Antifungal Susceptibility, and Molecular Epidemiology of Candida Species Causing Candidemia in a Tertiary Care Hospital in Bangkok, Thailand
por: Boonsilp, Siriphan, et al.
Publicado: (2021)

Impact of Nutritional Assessment on the Clinical Outcomes of Patients with Non-albicans Candidemia: A Multicenter Study
por: Lee, Yi-Chien, et al.
Publicado: (2021)

Antifungal tolerance is a subpopulation effect distinct from resistance and is associated with persistent candidemia
por: Rosenberg, Alexander, et al.
Publicado: (2018)

374. Candidemia Management and Associated Clinical Outcomes in Hospitalized Patients: An Opportunity for Antifungal Stewardship
por: Patel, Saloni, et al.
Publicado: (2018)

P020 Risk factors, speciation ,and antifungal susceptibility in candidemia patients: An observational study
por: Shujanya, Prateek, et al.
Publicado: (2022)

Clinical characteristics and risk factors of polymicrobial Staphylococcus aureus bloodstream infections
por: Zheng, Cheng, et al.
Publicado: (2020)

Correction: Clinical characteristics and risk factors of polymicrobial Staphylococcus aureus bloodstream infections
por: Zheng, Cheng, et al.
Publicado: (2022)

Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia
por: Seyoum, Elias, et al.
Publicado: (2020)

Risk Factors for and Clinical Outcomes of Polymicrobial Acinetobacter baumannii Bloodstream Infections
por: Qian, Zhenhua, et al.
Publicado: (2022)

The epidemiology, antifungal use and risk factors of death in elderly patients with candidemia: a multicentre retrospective study
por: Wang, Hao, et al.
Publicado: (2014)

Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection
por: Chen, Juan, et al.
Publicado: (2023)

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017)

Photodynamic Antifungal Activity of Hypocrellin A Against Candida albicans
por: Yang, Yijia, et al.
Publicado: (2019)

Recurrent episodes of Candidemia due to Candida glabrata, Candida tropicalis and Candida albicans with acquired echinocandin resistance
por: Grosset, Marine, et al.
Publicado: (2016)

High Recovery Rate of Non-albicans Candida Species Isolated From Burn Patients With Candidemia in Iran
por: Lotfi, Nazanin, et al.
Publicado: (2015)

Molecular Fingerprinting Studies Do Not Support Intrahospital Transmission of Candida albicans among Candidemia Patients in Kuwait
por: Asadzadeh, Mohammad, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ghevt05178ofd33ta5edcj3uod